The pharmaceutical market grew 29% in April and consolidates its recovery in 2025

The pharmaceutical market Venezuelan showed a strong dynamism during April 2025, registering an year -on -year growth of 29.10% and reaching the distribution of 32.3 million units, which represents 7.3 million more than in the same month of 2024. This was revealed by the Faro Pharmaceutical Bulletin, prepared by the business intelligence unit of the LETI group.

Final version

In the accumulated From January to April, the sector experienced an expansion of 17.52%with a total of 114.8 million units placed in pharmacies throughout the country.

National Industry leads the supply

According to the report, LNational laboratories were responsible for 87.82% of the total market growth in the first four -month period of the year.

This confirms that Local manufacturers are the main source of therapies supply For high morbidity diseases in the country, ”says the document.

During that period, The availability of the most demanded therapies was maintainedwith 10,069 registered active presentations.

This reflects the behavior by specialty, SMusculoskeletic isysma 36.33 %; diabetes and digestive system, 24.14 %; central nervous system, 20.58 %; antiparasitarios, 13.38 %; sense organs, 12.36 %; genitourinary system, 11.07 %; hormones, 8.59 %; cardiovascular system, 17.12 %; anti -infectious, 8.73 %; dermatological, 7.34 %; and respiratory system, 6.07 %.

The genericians gain ground and already represent 48% of the market

The generic medication segment continues winning participation and consolidating its presence in the country.

In April, this group grew 36.49 % year -on -year, with 15.7 million of distributed units.

In the first four months of the year, The accumulated rise was 26.05 %, reaching 55.1 million units, which is equivalent to 48 % of the total pharmaceutical market in units.

Of that total, 93.47 % It was produced by national laboratories, which ratifies the key role of local industry in the provision of accessible treatments.

Lower content presentations increase

Within the generic segment, the presentations of reduced content (lower quantity per package) also showed a strong growth. Between January and April, 47.11% increased compared to the same period of 2024, adding more than 25.2 million units.

These presentations represent the 46% of the total generic and 22% of the general pharmaceutical market, consolidating as a favorite option for consumers and sector growth engine.